期刊名称：OPEN FORUM INFECTIOUS DISEASES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Open Forum Infectious Diseases publishes clinical, translational, and basic research in a fully open access, online journal. It focuses on the intersection of biomedical science and clinical practice, with an emphasis on knowledge that could improve patient care globally. The journal's first and current (2017) Impact Factor is 3.240.
Instructions to Authors
OFID publishes original, de novo submissions, as well as submissions cascaded from IDSA’s other journals: Clinical Infectious Diseases and The Journal of Infectious Diseases . We particularly welcome manuscripts redirected with earlier reviews from IDSA’s other journals, which will facilitate a faster publication process.
OFID has a streamlined submission process designed to avoid unnecessary work. Manuscripts can be submitted in any common document format that can be easily opened and read by others. After initial review, you may be asked to supply editable files that match journal formatting requirements, and high-resolution figures. For more details, please consult the Manuscript Preparation Instructions.
Editorial Board
EDITOR-IN-CHIEF Paul E. Sax, MD is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), and Professor of Medicine at Harvard Medical School. He is Editor-in-Chief of Open Forum Infectious Diseases, is on the Peer Review board of the HIV/AIDS Section of UpToDate, the Editorial Board of NEJM Journal Watch Infectious Diseases (on which he writes the HIV and ID Observations blog), and the editorial advisory board of Medscape HIV/AIDS. In addition to his clinical and teaching work, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. Dr. Sax also writes the popular blog HIV and ID Observations. Find Dr. Sax on Twitter @PaulSaxMD.
DEPUTY EDITOR Jonathan Z. Li, MD is an Assistant Professor of Medicine in the Division of Infectious Diseases at the Brigham and Women’s Hospital and Harvard Medical School. He is the Director of the Harvard Virology Specialty Laboratory of the AIDS Clinical Trials Group and the Associate Director of the Harvard University Center for AIDS Research Clinical Core. Dr. Li is the chair of two clinical studies in the AIDS Clinical Trials Group and is the principal investigator of a translational virology laboratory. His research focus is in viral persistence, reservoirs, and drug resistance.
ASSOCIATE EDITORS John W. Baddley, MD, MSPH is a Professor of Medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). He serves as Director, Transplant Infectious Diseases at UAB and Director of the Infection Control Program at the Birmingham VA Medical Center. His clinical work focuses on management of infections in the immunocompromised host. In addition to his clinical and teaching work, Dr. Baddley's ongoing areas of research include clinical trials of antifungal and CMV therapies, epidemiology of fungal infections and safety of biological therapies. Find Dr. Baddley on Twitter @jobadd
 Jonathan Blum, MD, PhD is chief of infectious disease at Kaiser Permanente Medical Center in Santa Clara, California. He spends most of his time as a practicing clinician, along with work in antimicrobial stewardship, infection control, pharmacy administration, staff and resident education, and quality improvement. He is also interested in bacterial genetics and genomics.
 Johanna P Daily, MD, MS is an Associate Professor of in the Departments of Medicine in the Division of Infectious Diseases and Microbiology and Immunology at Albert Einstein College of Medicine. She carries out translational research on host pathogenbiology during natural Plasmodium falciparum infections to understand the mechanisms of disease in cerebral malaria and the development of clinical immunity. She provides general infectious disease care at Montefiore Medical Center.
 Donald Forthal, MD is a Professor of Medicine and of Molecular Biology and Biochemistry at the University of California, Irvine, where he is also the chief of the Division of Infectious Diseases. His research is primarily focused on understanding how antibodies bound to pathogens or to infected cells interact with host cells bearing Fc receptors. Such interactions are a critical component of how antibodies function either to prevent and control infections or to enhance pathogenesis. As a former Epidemic Intelligence Service officer with the Centers for Disease Control, Dr. Forthal maintains an interest in the epidemiology of viral infections. He has clinical interests in HIV and tropical infections.
 Inge Gyssens, MD PhD is internist and Professor of Infectious Diseases at Hasselt University, Belgium and senior researcher at Radboud University Medical Center, Nijmegen, The Netherlands. Her research interests focus on optimizing antimicrobial therapy and host-pathogen interaction. She has conducted epidemiological, pre-clinical and clinical research spanning a wide area of Infectious Diseases. She supports audits and intervention studies in Antimicrobial stewardship both in high- and low-resource countries. She has authored over 150 peer-reviewed articles and 15 book chapters. She is presently involved in a EU Horizon 2020 funded project on rapid molecular diagnostics, the FAPIC study. She serves as expert for WHO, EMA and ECDC. She is also Associate editor for Clinical Microbiology & Infection and Frontiers in Medicine.
 Kimberly Hanson, MD, MHS is an Associate Professor of Medicine and Pathology at the University of Utah School of Medicine. She has specialized expertise in the diagnosis and management of opportunistic viral, fungal and mycobacterial diseases. Her clinical and research interests focus on the diagnosis and management of infectious complications of transplantation and cancer care. She is board certified in infectious disease, medical microbiology, and general internal medicine.
 Keith S. Kaye, MD, MPH is a Professor of Medicine in the Division of Infectious Diseases and Department of Medicine at University of Michigan Medical School. He is the Director of Clinical Research in the Division of Infectious Diseases. Dr. Kaye’s particular academic interests and skills are epidemiology, management and outcomes associated with multi-drug resistant bacteria; antimicrobial stewardship; infections in the elderly; surgical site infection; and device-related infections. Dr. Kaye received his medical degree from the University of Pennsylvania and served his Internal Medicine residency and was an Infectious Diseases fellow at Beth Israel Deaconess Medical Center in Boston, MA. During fellowship, Dr. Kaye earned a Masters in Public Health from the Harvard School of Public Health. Dr. Kaye has authored over 200 peer-reviewed articles and 18 book chapters and has presented numerous abstracts at national conferences. Dr. Kaye has dedicated his entire career to infection prevention and antimicrobial stewardship and is recognized as an international leader expert in these disciplines. He currently is the PI on 2 NIH-funded trials evaluating the treatment of infections due to extremely-drug resistant (XDR) Gram-negative bacteria. Dr. Kaye has been an IDSA member and SHEA member for more than 15 years and is currently President-elect for SHEA.
 Maunank Shah, MD, PhD is an Associate Professor in the Division of Infectious Diseases, at Johns Hopkins University where he also co-directs the medical student course on microbiology and infectious diseases at Johns Hopkins School of Medicine. Maunank additionally serves as medical director for the Baltimore City Health Department TB program, serves as a clinical consultant for the CDC-Regional TB Training and Medical Consultation Center, and conducts TB educational activities through the Johns Hopkins Center for Clinical Global Health Education. Previously he has led studies to evaluate the performance and implementation of novel TB diagnostic tools in resource-limited settings. His continuing multi-disciplinary research efforts focus on development of decision-analytic and mathematical models to evaluate the epidemiologic and economic impact of HIV and TB interventions, and on evaluation of new mHealth tools to improve care(such as video-based directly-observed-therapy for TB and other diseases).
 Andrej Spec, MD, MSCI is an Assistant Professor in the Division of Infectious Disease at Washington University in St Louis, Missouri, where he also serves as the Associate Director of the Infectious Disease Clinical Research Unt and leads both the Invasive Mycoses Clinic as well as the Washington University Mycoses Group. He is the lead author of "Comprehensive Review of Infectious Disease." His clinical work focuses on invasive mycoses, especially in immunocompromised patients, such as patients with a transplant or congenital immunodeficiency. He does clinical and translational research in Candida spp., Cryptococcus spp. and Histoplasma capsulatum, and he is an active participant in antifungal development through his engagement with the Mycoses Study Group Education and Research Consortium. Find Dr. Spec on Twitter @FungalDoc
Abigail Zuger, MD is an Associate Clinical Professor of Medicine at Icahn School of Medicine at Mount Sinai and Senior Attending Physician at Mount Sinai Roosevelt and Mount Sinai St. Luke's Hospitals in New York City. She is a board-certified internist and infectious disease specialist with particular interest and expertise in HIV infection. Dr. Zuger has been a medical columnist and reporter for the New York Timessince 1997.
STATISTICAL EDITOR
Katie Mollan, MS
University of North Carolina
EDITORIAL ADVISORY BOARD
Jose R. Arribas, MD
Hospital La Paz, Madrid, Spain
Angela Caliendo, MD, FIDSA
Brown University
Daniel Diekema, MD, FIDSA
University of Iowa
Elizabeth Doby, MD
University of Utah
Jeannette Guarner, MD
Emory University
Kayoko Hayakawa, MD, PhD
Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan
Jennifer Horan, MD, PharmD
Duke University Medical Center
Vivek Jain, MD
University of North Carolina
Brian Kendall, MD
University of Utah
Bernard Macatangay, MD
University of Pittsburg
Patrick Mallon, PhD
University College Dublin School of Medicine and Medical Science, Dublin, Ireland
Dror Marchaim, MD
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Emily Toth Martin, PhD
University of Michigan School of Public Healh
Michael Mugavero, MD
University of Alabama at Birmingham
Marguerite Neill, MD, FIDSA
Brown University
Thomas Patterson, MD, FIDSA
University of Texas Health Science Center at San Antonio
Cathy Petti, MD
University of South Florida
Jason M. Pogue, PharmD, BCPS-ID
Detroit Medical Center
Jesús Rodríguez-Baño, MD, PhD
Universidad de Sevilla, Spain
Brian Schwartz, MD
University of California, San Francisco
Irini Sereti, MD
National Institutes of Health
David L. Thomas, MD, FIDSA
Johns Hopkins University
Joseph Tucker, MD, PhD
University of North Carolina
David L. Wyles, MD
University of California, San Diego
St. Luke’s Roosevelt Hospital Center
OFID PODCAST PRODUCER
Meredith Mazzotta
|
